171 related articles for article (PubMed ID: 18097956)
1. Restricted lateral mobility of plasma membrane CD4 impairs HIV-1 envelope glycoprotein mediated fusion.
Rawat SS; Zimmerman C; Johnson BT; Cho E; Lockett SJ; Blumenthal R; Puri A
Mol Membr Biol; 2008 Jan; 25(1):83-94. PubMed ID: 18097956
[TBL] [Abstract][Full Text] [Related]
2. The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion.
Ablan S; Rawat SS; Viard M; Wang JM; Puri A; Blumenthal R
Virol J; 2006 Dec; 3():104. PubMed ID: 17187670
[TBL] [Abstract][Full Text] [Related]
3. Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion.
Rawat SS; Eaton J; Gallo SA; Martin TD; Ablan S; Ratnayake S; Viard M; KewalRamani VN; Wang JM; Blumenthal R; Puri A
Virology; 2004 Jan; 318(1):55-65. PubMed ID: 14972535
[TBL] [Abstract][Full Text] [Related]
4. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
Lee S; Lapham CK; Chen H; King L; Manischewitz J; Romantseva T; Mostowski H; Stantchev TS; Broder CC; Golding H
J Virol; 2000 Jun; 74(11):5016-23. PubMed ID: 10799575
[TBL] [Abstract][Full Text] [Related]
5. Fusion of HIV-1 envelope-expressing cells to human glomerular endothelial cells through an CXCR4-mediated mechanism.
Ray PE; Soler-García AA; Xu L; Soderland C; Blumenthal R; Puri A
Pediatr Nephrol; 2005 Oct; 20(10):1401-9. PubMed ID: 16047221
[TBL] [Abstract][Full Text] [Related]
6. Conserved changes in envelope function during human immunodeficiency virus type 1 coreceptor switching.
Pastore C; Nedellec R; Ramos A; Hartley O; Miamidian JL; Reeves JD; Mosier DE
J Virol; 2007 Aug; 81(15):8165-79. PubMed ID: 17507486
[TBL] [Abstract][Full Text] [Related]
7. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
[TBL] [Abstract][Full Text] [Related]
8. Promonocytic U937 subclones expressing CD4 and CXCR4 are resistant to infection with and cell-to-cell fusion by T-cell-tropic human immunodeficiency virus type 1.
Moriuchi H; Moriuchi M; Arthos J; Hoxie J; Fauci AS
J Virol; 1997 Dec; 71(12):9664-71. PubMed ID: 9371631
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type 1 fusion.
Rawat SS; Gallo SA; Eaton J; Martin TD; Ablan S; KewalRamani VN; Wang JM; Blumenthal R; Puri A
J Virol; 2004 Jul; 78(14):7360-8. PubMed ID: 15220409
[TBL] [Abstract][Full Text] [Related]
10. Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytes.
König RR; Flory E; Steidl S; Neumann J; Coulibaly C; Holznagel E; Holzammer S; Norley S; Cichutek K
J Virol; 2002 Nov; 76(21):10627-36. PubMed ID: 12368305
[TBL] [Abstract][Full Text] [Related]
11. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.
Hill CM; Deng H; Unutmaz D; Kewalramani VN; Bastiani L; Gorny MK; Zolla-Pazner S; Littman DR
J Virol; 1997 Sep; 71(9):6296-304. PubMed ID: 9261346
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells.
Popik W; Alce TM; Au WC
J Virol; 2002 May; 76(10):4709-22. PubMed ID: 11967288
[TBL] [Abstract][Full Text] [Related]
13. The role of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment.
Melikyan GB; Platt EJ; Kabat D
Retrovirology; 2007 Aug; 4():55. PubMed ID: 17686153
[TBL] [Abstract][Full Text] [Related]
14. Role of Abl kinase and the Wave2 signaling complex in HIV-1 entry at a post-hemifusion step.
Harmon B; Campbell N; Ratner L
PLoS Pathog; 2010 Jun; 6(6):e1000956. PubMed ID: 20585556
[TBL] [Abstract][Full Text] [Related]
15. Targeting of HIV- and SIV-infected cells by CD4-chemokine receptor pseudotypes.
Endres MJ; Jaffer S; Haggarty B; Turner JD; Doranz BJ; O'Brien PJ; Kolson DL; Hoxie JA
Science; 1997 Nov; 278(5342):1462-4. PubMed ID: 9367958
[TBL] [Abstract][Full Text] [Related]
16. Fusion Stage of HIV-1 Entry Depends on Virus-Induced Cell Surface Exposure of Phosphatidylserine.
Zaitseva E; Zaitsev E; Melikov K; Arakelyan A; Marin M; Villasmil R; Margolis LB; Melikyan GB; Chernomordik LV
Cell Host Microbe; 2017 Jul; 22(1):99-110.e7. PubMed ID: 28704658
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5.
Davis CB; Dikic I; Unutmaz D; Hill CM; Arthos J; Siani MA; Thompson DA; Schlessinger J; Littman DR
J Exp Med; 1997 Nov; 186(10):1793-8. PubMed ID: 9362541
[TBL] [Abstract][Full Text] [Related]
18. Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5.
Hug P; Lin HM; Korte T; Xiao X; Dimitrov DS; Wang JM; Puri A; Blumenthal R
J Virol; 2000 Jul; 74(14):6377-85. PubMed ID: 10864648
[TBL] [Abstract][Full Text] [Related]
19. Affinofile profiling: how efficiency of CD4/CCR5 usage impacts the biological and pathogenic phenotype of HIV.
Chikere K; Chou T; Gorry PR; Lee B
Virology; 2013 Jan; 435(1):81-91. PubMed ID: 23217618
[TBL] [Abstract][Full Text] [Related]
20. Real-time analysis of human immunodeficiency virus type 1 Env-mediated membrane fusion by fluorescence resonance energy transfer.
Furuta RA; Nishikawa M; Fujisawa J
Microbes Infect; 2006 Feb; 8(2):520-32. PubMed ID: 16300985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
